Mobile Menu

Search Results

Search results for: Industry

Continuomics and the future of clinical trials

“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]

“Our geneticist could only find three published articles about the GRIN1 gene at the time” – Interview with Jillian Hastings Ward, Chair of the Participant Panel at Genomics England

Jillian Hastings Ward is Chair of the Participant Panel at Genomics England. The Panel acts as an advisory body to the Genomics England board to ensure that the data collected by the 100,000 Genomes Project is being used for the best interests of the participants.

Enabling Precision medicine for everyone: New pharmacogenomics solution launched in the US

The PGx program is an industry-first solution that will protect patients from being prescribed ineffective or harmful drugs.

“We need to have resilience and tolerance for failure” – Interview with Guillermo Del Angel, Alexion Pharmaceuticals

FLG: Can you introduce yourself and your work? I’m Guillermo del Angel and I’m the Senior Director for Data Science […]

“We are starting to appreciate non-coding DNA” – Interview with Dr Sandra Smieszek, Vanda Pharmaceuticals Inc.

FLG: Can you introduce yourself and your work? I’m Sandra Smieszek and I’m the Head of Genetics at Vanda Pharmaceuticals […]

Interview with Dr Halima Moncrieffe, Assistant Professor, Cincinnati Children’s Hospital Medical Center

Dr Halima Moncrieffe is an Assistant Professor at Cincinnati Children’s Hospital, ranked top 3 in the USA, where she combines genomics with immunology to understand medication response and disease etiology. Halima is an award-winning immunologist who’s ultimate goal is to move towards a cure for Juvenile Idiopathic Arthritis, so children can live pain-free and to their full potential

Interview with Dr Michelle Krishnan, Translational Medicine Leader in Rare Diseases, Roche

Dr Michelle Krishnan is the Translational Medicine Leading in Rare Diseases at Roche where she focuses on developing transformative therapies […]

FoG 2020 Presentation Sheela Upadhyaya, NICE: The Role of NICE in Enabling Access to New Medicines

Associate Director – Highly Specialised Technologies, NICE Sheela Upadhyaya is currently the Associate Director of the Highly Specialised Technology program […]

FoG 2020 Presentation Neil Walker, NIHR BioResource: How to add NHS data to a research project

Neil Walker is IT Lead at the NIHR BioResource, a richly phenotyped and genotyped panel of participants who can be […]

FoG 2020 Presentation Michael Barnes, QMUL: RNA Sequencing and Machine Learning as Molecular Scalpels

Professor of Bioinformatics, Director, the Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London Co-Investigator, Health […]